NDC 51662-1565

LIDOCAINE HCI AND DEXTROSE

Lidocaine Hci And Dextrose

LIDOCAINE HCI AND DEXTROSE is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Dextrose Monohydrate; Lidocaine Hydrochloride Anhydrous.

Product ID51662-1565_c75311e3-ca6f-40de-e053-2a95a90a1bda
NDC51662-1565
Product TypeHuman Prescription Drug
Proprietary NameLIDOCAINE HCI AND DEXTROSE
Generic NameLidocaine Hci And Dextrose
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2021-07-17
Marketing CategoryNDA /
Application NumberNDA019830
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NameDEXTROSE MONOHYDRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS
Active Ingredient Strength5 g/100mL; g/100mL
Pharm ClassesAmide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 51662-1565-1

250 mL in 1 CONTAINER (51662-1565-1)
Marketing Start Date2021-07-17
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "LIDOCAINE HCI AND DEXTROSE" or generic name "Lidocaine Hci And Dextrose"

NDCBrand NameGeneric Name
51662-1302LIDOCAINE HCI AND DEXTROSELIDOCAINE HCI AND DEXTROSE
51662-1565LIDOCAINE HCI AND DEXTROSELIDOCAINE HCI AND DEXTROSE

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.